Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SKIN ELEMENTS LIMITED Director's Dealing 2026

May 6, 2026

65803_rns_2026-05-06_85a931c4-7e33-4593-95d6-9a7f14ee3cdf.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Skin Elements Limited ASX ANNOUNCEMENT
ASX CODE:SKN

7th May 2026.

Amendment to Appendix 3Y Peter Malone

Skin Elements Limited (Company) advises that an erroneous omission of value/consideration has been identified in an Appendix 3Y for Mr Peter Malone, lodged with ASX on 24th December 2025, the Company therefore provides an amended and updated Appendix 3Y as attached.

This ASX announcement has been authorised for release by the Company Secretary, Stuart Usher.

ENDS

For further information, please contact:

Peter Malone
Executive Chairman
Skin Elements Limited
T: +61 439 430 770
E: [email protected]

Media and Investor Inquiries
James Moses
Mandate Corporate
T: +61 420 991 574
E:[email protected]

About Skin Elements

Skin Elements (ASX: SKN) is an award winning Australian owned and operated ASX-listed biotechnology healthcare company focused on the commercialisation of the anti-microbial SE Formula™ through a range of natural and organic health care products. Skin Elements innovative approach to plant-based and organic personal care and skincare products has enabled the creation of a portfolio of products that have been sold and distributed across the world. Its flagship products include the SuprCuvr TGA-registered, hospital-grade plant-based disinfectant, Eco Nurture plant bio-stimulant, Invisi Shield alcohol free natural sanitiser, TGA registered Soléo Organics natural and organic sunscreen, TGA registered PapayaActivs natural therapeutics skincare and Elizabeth Jane Natural Cosmetics brand.

Further information is available via the Company website: www.skinelementslimited.com and on the Company online store: www.sknlife.com.au

Natural Science by Skin Elements

1242 Hay Street, West Perth
Western Australia, 6005
P 08 6311 1900
www.sknlife.com.au
www.skinelementslimited.com
[email protected]


Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y [amended 3Y lodged 24-Dec 2025]

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SKIN ELEMENTS LIMITED
ABN 90 608 047 794

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director PETER MALONE
Date of last notice 22 December 2025

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest (including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest. Empire Services (AUST) Pty Ltd – Mr Malone is the sole director and shareholder of this company and the company acts as Trustee for trusts of which Mr Malone is a beneficiary
Date of change 17 December 2025
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1


Appendix 3Y

Change of Director's Interest Notice

| No. of securities held prior to change | 31,743,116 ordinary fully paid shares
5,290,520 Options exercisable at $0.025 (SKNOD) expiring 31 May 2026
held by Sovereign Empire Pty Ltd for which Mr Malone is a director and a beneficiary.

106,620,000 Ordinary Shares
50,000,000 performance rights – Class B Held by Josaxa Pty Ltd Mr Malone is the sole director and the company acts as Trustee for trusts of which Mr Malone is a beneficiary

400,000,000 Ordinary Shares
200,000,000 Options exercisable at $0.006 expiring 12 December 2028 Held Empire Services (AUST) Pty Ltd Mr Malone is the sole director and shareholder and the company acts as Trustee for trusts of which Mr Malone is a beneficiary |
| --- | --- |
| Class | Ordinary Fully Paid Shares
Options exercisable at $0.006 expiring 12 December 2028 |
| Number acquired | 119,025,000 Ordinary Fully Paid Shares on conversion of options Held Empire Services (AUST) Pty Ltd

163,050,000 Ordinary Fully paid Shares (Josaxa Pty Ltd |
| Number disposed | 119,025,000 - on conversion of Options exercisable at $0.006 expiring 12 December 2028

163,050,000 Ordinary Shares (transferred between holdings to Josaxa Pty Ltd)

211,950,000 Ordinary Shares |

  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011


Appendix 3Y

Change of Director's Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation 119,025,000 ordinary fully paid shares at $0.006 per share (on conversion of 119,025,000 options) 163,050,000 ordinary fully paid shares at $0.005 per share (163,050,000) ordinary fully paid shares at $0.005 per share (211,950,000) ordinary fully paid shares at $0.005 per share
No. of securities held after change 31,743,116 ordinary fully paid shares 5,290,520 Options exercisable at $0.025 (SKNOD) expiring 31 May 2026 held by Sovereign Empire Pty Ltd for which Mr Malone is a director and a beneficiary. 269,670,000 Ordinary Shares 50,000,000 performance rights – Class B Held by Josaxa Pty Ltd Mr Malone is the sole director and the company acts as Trustee for trusts of which Mr Malone is a beneficiary 144,025,000 Ordinary Shares 80,975,000 Options exercisable at $0.006 expiring 12 December 2028 Held Empire Services (AUST) Pty Ltd Mr Malone is the sole director and shareholder and the company acts as Trustee for trusts of which Mr Malone is a beneficiary
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Ordinary Shares & Options Issued upon Conversion of shares and OMT of Ordinary Shares

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract N/A
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3


Appendix 3Y

Change of Director's Interest Notice

Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change
Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 – +Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? N/A
If so, was prior written clearance provided to allow the trade to proceed during this period? N/A
If prior written clearance was provided, on what date was this provided? N/A
  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011